Anti-interleukin-15-vaccine (CIGB)

N/A

Report date: 2022/03/04 16:53:49

Base Information

Drug NameAnti-interleukin-15-vaccine (CIGB)
Drug Alias NameAnti-IL-15-vaccine-CIGBCIGB-50
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCenter For Genetic Engineering And BiotechnologyHeber Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCenter For Genetic Engineering And BiotechnologyHeber Biotech
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A